Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in So... ( JOHANNESBURG and PITTSBURGH Hea...)

Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa

Date:2/23/2013

JOHANNESBURG and PITTSBURGH, Feb. 23, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products. South Africa has the world's largest HIV/AIDS population, with approximately 5.6 million¹ people living with the disease and an estimated 1.7 million² people receiving treatment.

Mylan's South African ARV portfolio initially will consist of 11 first- and second-line adult and pediatric regimens. Included are several innovative products, such as fixed-dose combinations, single blister "co-packs," heat-stable products and novel pediatric formulations that have been approved by the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO).

Mylan CEO Heather Bresch commented, "Mylan's mission is to provide the world's 7 billion people with access to high quality medicine. Recently, Mylan was awarded a 19% share of the ARV tender conducted by the South African government and we already have begun to deliver on this commitment. Building on this, today we are pleased to launch a broad and innovative ARV portfolio for the private sector. We believe that Mylan can set a new standard in the treatment of HIV/AIDS in South Africa by providing health care providers and those living with the disease access to high quality, affordable medicines."

Paul Miller , managing director and vice president of Mylan's South African business noted, "Mylan is an established leader in ARVs, with a global portfolio of 43 high quality ARVs, and the compa
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
2. Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference Call and Live Webcast
3. Mylan Appoints Melina Higgins and Rajiv Malik to Board of Directors
4. Mylan Announces Pricing of Senior Notes
5. Moodys and Standard & Poors Upgrade Mylan to Investment Grade Credit Ratings
6. Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83
7. Mylan Selected as a Leading ARV Supplier to Indias National AIDS Control Organization
8. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
9. Mylan Launches Lithium Carbonate Extended-Release Tablets USP
10. Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
11. Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade

Post Your Comments:

(Date:5/21/2013)... May 21, 2013 Decision Resources, one ... firms for pharmaceutical and healthcare issues, finds ... on key efficacy endpoints, including overall survival ... most influence over surveyed U.S. and European ... positive, HER2-negative breast cancer. The two novel ...

(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...

(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...

Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 3 BioElectronics Presents FDA Reclassification Panel 2 BioElectronics Presents FDA Reclassification Panel 3

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] BioElectronics Presents FDA Reclassification Panel

... 26 Todd Bluedorn, chief executive officer of Lennox International ... at the J.P. Morgan HVAC Conference on Thursday, May 28 ... presentation materials can be accessed on the company,s website at ... archived for 60 days. The webcast can also be ...

... Health, Inc. (TH) is pleased to announce its involvement in ... Komen Foundation. TH,s collaborator, Duke University , was ... million of investment by the foundation in 2009 to further ... cancer.The Susan G. Komen for the Cure(R) is a nonprofit ...

Cached Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2 Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3

Lennox International to Present at J.P. Morgan Conference Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R)

(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...

(Date:5/21/2013)... Australia (PRWEB) May 22, 2013 About ... made the Fertility Clinics industry one of ... industry assists patients who are unable to conceive naturally ... and popular of which is in-vitro fertilisation (IVF) cycles. ... IVF cycles in Australia has increased by 4.4% per ...

(Date:5/21/2013)... in St. Louis announced today that it is ... by the Bill & Melinda Gates Foundation. Tae ... & chemical engineering, will pursue an innovative global ... of Parasite Eggs by Probiotic Organisms." , Grand ... ideas that can break the mold in how ...

(Date:5/21/2013)... Dayton, OH (PRWEB) May 21, 2013 ... is associated with an increased risk for CKD progression ... at Dayton Children’s Hospital and Johns Hopkins University has ... disease who are exposed to secondhand smoke. , ... years is the first study of the effect of ...

(Date:5/21/2013)... Columbia, MO (PRWEB) May 21, 2013 The ... 2,500 athletes and coaches from across the state to Columbia. ... campuses of the University of Missouri and Columbia College, and ... , The State Summer Games officially kick off at 7:30 ... Ceremony will feature a Go Wild! theme, the Parade of ...

Breaking Medicine News(10 mins):Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2 Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3 Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2 Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3 Health News:Gates Fellowship addresses parasite infection in developing world 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3

[0] Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease [0] Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld [0] Gates Fellowship addresses parasite infection in developing world [0] Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study [0] Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia

... demands the immediate release of three Sri Lankan physicians whom the Sri ... ... (Vocus) May 18, 2009 -- Physicians for Human Rights (PHR) ... Lankan Army (SLA) detained on May 16, 2009. A Minister of Health ...

... (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today ... , Financial Highlights from the First Quarter Ended ... to $39.3 million from $18.1 million in, ... profit increased to $20.7 million from $7.7 million in the prior, ...

... 18 Beckman Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical testing, today ... of its common stock, to finance in part ... of Olympus Corporation,s Life Science business, or the acquisition. ...

... The Quigley Corporation, (Nasdaq: QG L ... , today announced an update on the Company,s ... announcement regarding the unexpected positive finding for its QR-333 ... 11b clinical trial. While the complete statistical results of ...

... suggests that evolution needed only a few genetic changes to ... comparing the fetal development of the eye of the owl ... only a minor difference in the timing of cell proliferation ... of eyes.The findings help scientists understand how a structure as ...

... Cincinnati (UC) cancer and cell biologists have identified a ... prostate cancers. , In a preclinical study ... that simultaneous inactivation of two particular genesknown as ... cancer tumors in mice. , "We knew that ...

Physicians for Human Rights Calls for the Release of Sri Lankan Doctors BMP Sunstone Reports First Quarter 2009 Financial Results Beckman Coulter, Inc. Announces Common Stock Offering The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure New Insight Into Primate Eye Evolution Research reveals molecular pathway behind invasive prostate cancers

MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...

... offers five classes of resectoscope electrodes ... loops, knife, roller bar & ball, ... only electrodes specifically integrated into the ... removal with minimal bleeding, increased visibility, ...

... and MRO™-2005 Rigid Percutaneous Nephroscopes combine ... throughput capacity with proven MRO performance. ... with small size sheaths. The MRO™-20 ... easy positioning during percutaneous procedures. The ...

... Resectoscope is based on the award winning ... the surgeon to perform TURis - resection ... element, HF cable and electrodes, Olympus OES ... in saline, supporting both, standard TUR and ...

Medicine Products:

MT-BT-5011 Prostate Seeding Needle USA Elite System™ & USA Series™ Roller Bar Electrode USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes SurgMaster OES Pro Resectoscope